# MPLX LP: financial statements, quarterly

MPLX · NYSE · CIK 1552000 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mplx.md) · [Financials](/companies/mplx/financials.md) · [Filings](/companies/mplx/filings.md) · [Insiders](/companies/mplx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mplx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,283](/filings/0001552000-24-000033.md) | [2,247 d](/filings/0001552000-26-000009.md) | [2,172](/filings/0001552000-25-000019.md) | [2,255](/filings/0001552000-25-000026.md) | [2,345](/filings/0001552000-25-000036.md) | [2,417 d](/filings/0001552000-26-000009.md) | [2,460](/filings/0001552000-26-000025.md) | [2,356](/filings/0001552000-26-000038.md) | [2,459](/filings/0001552000-25-000036.md) | [2,451 d](/filings/0001552000-26-000009.md) | [2,349](/filings/0001552000-26-000025.md) | [2,615](/filings/0001552000-26-000038.md) |
| Operating income | $m | [1,154](/filings/0001552000-24-000033.md) | [1,375 d](/filings/0001552000-26-000009.md) | [1,251](/filings/0001552000-25-000019.md) | [1,419](/filings/0001552000-25-000026.md) | [1,275](/filings/0001552000-25-000036.md) | [1,343 d](/filings/0001552000-26-000009.md) | [1,366](/filings/0001552000-26-000025.md) | [1,293](/filings/0001552000-26-000038.md) | [1,801](/filings/0001552000-25-000036.md) | [1,483 d](/filings/0001552000-26-000009.md) | [1,214](/filings/0001552000-26-000025.md) | [1,378](/filings/0001552000-26-000038.md) |
| Income tax | $m | [1.0](/filings/0001552000-24-000033.md) | [9.0 d](/filings/0001552000-25-000012.md) | [1.0](/filings/0001552000-25-000019.md) | [2.0](/filings/0001552000-25-000026.md) | [2.0](/filings/0001552000-25-000036.md) | [5.0 d](/filings/0001552000-25-000012.md) | [1.0](/filings/0001552000-26-000025.md) | [1.0](/filings/0001552000-26-000038.md) | [3.0](/filings/0001552000-25-000036.md) | not reported | [1.0](/filings/0001552000-26-000025.md) | [2.0](/filings/0001552000-26-000038.md) |
| Net income | $m | [918](/filings/0001552000-23-000038.md) | [1,134 d](/filings/0001552000-24-000007.md) | [1,015](/filings/0001552000-25-000019.md) | [1,186](/filings/0001552000-25-000026.md) | [1,047](/filings/0001552000-25-000036.md) | [1,109 d](/filings/0001552000-26-000009.md) | [1,136](/filings/0001552000-26-000025.md) | [1,058](/filings/0001552000-26-000038.md) | [1,555](/filings/0001552000-25-000036.md) | [1,203 d](/filings/0001552000-26-000009.md) | [922](/filings/0001552000-26-000025.md) | [1,087](/filings/0001552000-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0001552000-23-000038.md) | [1.0](/filings/0001552000-25-000012.md) | [0.4](/filings/0001552000-24-000014.md) | [2.5](/filings/0001552000-24-000026.md) | [2.4](/filings/0001552000-24-000033.md) | [1.5](/filings/0001552000-26-000009.md) | [2.5](/filings/0001552000-25-000019.md) | [1.4](/filings/0001552000-25-000026.md) | [1.8](/filings/0001552000-25-000036.md) | [2.1](/filings/0001552000-26-000038.md) | [1.5](/filings/0001552000-26-000025.md) | [1.0](/filings/0001552000-26-000038.md) |
| Current assets | $bn | [2.7](/filings/0001552000-23-000038.md) | [2.8](/filings/0001552000-25-000012.md) | [2.1](/filings/0001552000-24-000014.md) | [4.2](/filings/0001552000-24-000026.md) | [4.2](/filings/0001552000-24-000033.md) | [3.3](/filings/0001552000-26-000009.md) | [4.5](/filings/0001552000-25-000019.md) | [3.2](/filings/0001552000-25-000026.md) | [4.6](/filings/0001552000-25-000036.md) | [4.0](/filings/0001552000-26-000038.md) | [3.5](/filings/0001552000-26-000025.md) | [2.9](/filings/0001552000-26-000038.md) |
| Total assets | $bn | [36.1](/filings/0001552000-23-000038.md) | [36.5](/filings/0001552000-25-000012.md) | [36.5](/filings/0001552000-24-000014.md) | [38.4](/filings/0001552000-24-000026.md) | [38.5](/filings/0001552000-24-000033.md) | [37.5](/filings/0001552000-26-000009.md) | [39.0](/filings/0001552000-25-000019.md) | [37.8](/filings/0001552000-25-000026.md) | [43.2](/filings/0001552000-25-000036.md) | [43.0](/filings/0001552000-26-000038.md) | [42.9](/filings/0001552000-26-000025.md) | [43.0](/filings/0001552000-26-000038.md) |
| Current liabilities | $bn | [1.4](/filings/0001552000-23-000038.md) | [2.6](/filings/0001552000-25-000012.md) | [3.0](/filings/0001552000-24-000014.md) | [4.2](/filings/0001552000-24-000026.md) | [4.3](/filings/0001552000-24-000033.md) | [3.2](/filings/0001552000-26-000009.md) | [4.2](/filings/0001552000-25-000019.md) | [3.1](/filings/0001552000-25-000026.md) | [3.5](/filings/0001552000-25-000036.md) | [3.2](/filings/0001552000-26-000038.md) | [3.2](/filings/0001552000-26-000025.md) | [3.2](/filings/0001552000-26-000038.md) |
| Total liabilities | $bn | [22.8](/filings/0001552000-23-000038.md) | [22.9](/filings/0001552000-25-000012.md) | [22.8](/filings/0001552000-24-000014.md) | [24.5](/filings/0001552000-24-000026.md) | [24.5](/filings/0001552000-24-000033.md) | [23.5](/filings/0001552000-26-000009.md) | [24.9](/filings/0001552000-25-000019.md) | [23.8](/filings/0001552000-25-000026.md) | [28.7](/filings/0001552000-25-000036.md) | [28.5](/filings/0001552000-26-000038.md) | [28.6](/filings/0001552000-26-000025.md) | [28.7](/filings/0001552000-26-000038.md) |
| Current portion of debt | $bn | not reported | [1.1](/filings/0001552000-25-000012.md) | not reported | not reported | not reported | [1.7](/filings/0001552000-26-000009.md) | not reported | not reported | not reported | [1.5](/filings/0001552000-26-000009.md) | not reported | not reported |
| Shareholders' equity | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,244 d](/filings/0001552000-24-000033.md) | [1,489 d](/filings/0001552000-26-000009.md) | [1,291](/filings/0001552000-25-000019.md) | [1,565 d](/filings/0001552000-25-000026.md) | [1,415 d](/filings/0001552000-25-000036.md) | [1,675 d](/filings/0001552000-26-000009.md) | [1,246](/filings/0001552000-26-000025.md) | [1,736 d](/filings/0001552000-26-000038.md) | [1,431 d](/filings/0001552000-25-000036.md) | [1,496 d](/filings/0001552000-26-000009.md) | [1,347](/filings/0001552000-26-000025.md) | [1,702 d](/filings/0001552000-26-000038.md) |
| Capital expenditure | $m | [230 d](/filings/0001552000-24-000033.md) | [275 d](/filings/0001552000-26-000009.md) | [255](/filings/0001552000-25-000019.md) | [213 d](/filings/0001552000-25-000026.md) | [280 d](/filings/0001552000-25-000036.md) | [308 d](/filings/0001552000-26-000009.md) | [267](/filings/0001552000-26-000025.md) | [301 d](/filings/0001552000-26-000038.md) | [526 d](/filings/0001552000-25-000036.md) | [714 d](/filings/0001552000-26-000009.md) | [575](/filings/0001552000-26-000025.md) | [825 d](/filings/0001552000-26-000038.md) |
| Share repurchases | $m | [0.0](/filings/0001552000-24-000033.md) | [0.0 d](/filings/0001552000-26-000009.md) | [75.0](/filings/0001552000-25-000019.md) | [75.0](/filings/0001552000-25-000026.md) | [76.0](/filings/0001552000-25-000036.md) | [100 d](/filings/0001552000-26-000009.md) | [100](/filings/0001552000-26-000025.md) | [100](/filings/0001552000-26-000038.md) | [100](/filings/0001552000-25-000036.md) | [100 d](/filings/0001552000-26-000009.md) | [50.0](/filings/0001552000-26-000025.md) | [50.0](/filings/0001552000-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 1,013,858,251 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001552000-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.